Vir Biotechnology, Inc.
VIR· Nasdaq
Released May 5, 2022, after the close
10-Q filed May 5, 2022, 35 days after period end · 0000950170-22-007811
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $1.23B | $1.98M | $5.72M | $3.66M |
| Net Income | $518.62M | -$168.91M | -$77.24M | -$28.67M |
| EPS Diluted |
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR
| $3.85 |
| -$1.32 |
| -$0.71 |
| -$3.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.